If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,854.00    3.00 (0.16%)
Bid:
1,848.00
Ask:
1,849.00
Spread: 1.00 (0.054%)
Market Cap: £5.95b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Director/PDMR Shareholding

3 Aug 2016 18:12

RNS Number : 1936G
Hiscox Ltd
03 August 2016
 

 

Hiscox Ltd

 

(the 'Company')

 

Notification of transactions by Persons Discharging Managerial Responsibilities ('PDMR')

 

 

Hamilton, Bermuda - The Company has been notified by Mr Richard Watson, a Director, that on 2 August 2016 he exercised nil-cost options under the Performance Share Plan to acquire 134,837 Ordinary Shares of 6.5p per share ("Shares"). On the same date Mr Watson sold 96,234 Shares at a price of 1083.862p per share. The transactions were executed in GBP. The notification made in accordance with the requirements of the EU Market Abuse Regulation (EU 596/2014) is set out below.

 

Following these transactions Mr Watson remains interested in 750,000 Ordinary Shares.

 

Jeremy Pinchin

 

Company Secretary

Hiscox Ltd

+ 1 441 278 8300

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Richard Watson

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director and Chief Underwriting Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Hiscox Ltd

b)

 

LEI

 

 

5493007JXOLJ0QCY2D70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of 6.5p each

 

ISIN: BMG4593F1389

 

 

b)

 

Nature of the transaction

 

 

Exercise of options under the Performance Share Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil cost options

 

134,837

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

134,837

 

 

Nil cost options

 

 

e)

 

Date of the transaction

 

 

2 August 2016

f)

 

Place of the transaction

 

 

Outside a trading venue

5

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary Shares of 6.5p each

 

ISIN: BMG4593F1389

 

 

b)

 

Nature of the transaction

 

 

Sale of Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1083.86230438p

 

96,234

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

96,234

 

 

£1,043,044.05 (aggregate price)

 

e)

 

Date of the transaction

 

 

2 August 2016

f)

 

Place of the transaction

 

 

XLON

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBLGDILSGBGLX
Date   Source Headline
9th Mar 20237:00 amRNSSyndicates 33 and 6104 – results and estimates
8th Mar 20237:01 amRNSFull Year Results
8th Mar 20237:00 amRNSRobert Childs to retire from the Board as Chairman
2nd Mar 20237:00 amRNSTotal Voting Rights to 28 February 2023
1st Feb 20234:55 pmRNSTotal Voting Rights
16th Jan 20233:13 pmRNSDirector/PDMR Shareholding
13th Jan 20236:12 pmRNSAveva Group
7th Dec 20222:21 pmRNSDirector/PDMR Shareholding
1st Dec 202212:45 pmRNSTotal Voting Rights
28th Nov 20227:00 amRNSDirector PDMR Shareholding
14th Nov 202211:08 amRNSSyndicates 33 and 6104 – results and estimates
2nd Nov 20227:00 amRNSQ3 2022 Trading Statement
1st Nov 20224:19 pmRNSTotal Voting Rights
3rd Oct 20225:06 pmRNSTotal Voting Rights
26th Sep 20224:09 pmRNSDirector/PDMR Shareholding
22nd Sep 202211:00 amRNSDirector/PDMR Shareholding
15th Sep 20222:13 pmRNSApplication to be Admitted to the Official List
7th Sep 202212:04 pmRNSAnnouncement of the Scrip Reference Share price
6th Sep 20225:10 pmRNSDirector/PDMR Shareholding
1st Sep 20222:04 pmRNSTotal Voting Rights
12th Aug 20221:38 pmRNSDirector PDMR Shareholding
10th Aug 202212:29 pmRNSSyndicate Results
9th Aug 202211:05 amRNSDirector/PDMR Shareholding
3rd Aug 20227:00 amRNSInterim Report
6th Jul 202211:35 amRNSTotal Voting Rights
15th Jun 20222:05 pmRNSDirector/PDMR Shareholding
9th Jun 20221:09 pmRNSApplication to be Admitted to the Official List
31st May 20223:29 pmRNSAnnouncement of Scrip Reference Share Price
17th May 20225:30 pmRNSDirector/PDMR Shareholding
13th May 20223:30 pmRNSAppointment of Paul Cooper
13th May 20223:15 pmRNSAGM Results
10th May 202210:38 amRNSSyndicates 33 and 6104 – results and estimates
5th May 20227:00 amRNSTrading Statement
3rd May 202212:27 pmRNSTotal Voting Rights
21st Apr 20221:32 pmRNSTR-1 Standard form-notification major shareholding
11th Apr 20224:45 pmRNSNotice of 2022 Annual General Meeting
11th Apr 20222:43 pmRNSDirector/PDMR Shareholding
7th Apr 202211:07 amRNSDirector/PDMR Shareholding
1st Apr 202212:29 pmRNSTotal Voting Rights
29th Mar 20224:47 pmRNSDirector PDMR Shareholding
11th Mar 20224:27 pmRNS2021 Annual Report and Accounts
7th Mar 20226:10 pmRNSDirector/PDMR Shareholding
4th Mar 202210:55 amRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20227:00 amRNSFull Year Results
1st Mar 202212:15 pmRNSTotal Voting Rights
2nd Feb 20227:42 amRNSTR-1 Standard Form-Notification Major Shareholding
1st Feb 20225:03 pmRNSDirector/PDMR Shareholding
1st Feb 20225:03 pmRNSTotal Voting Rights
4th Jan 20227:00 amRNSTotal Voting Rights
21st Dec 20217:00 amRNSAppointment of Group Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.